“Design And Development Of A Novel Formulation Of Pacritinib For Treatment Of Adults Intermediate And High Risk Myelofibrosis With Low Platelet Count”. Journal of Pharmaceutical Negative Results (January 15, 2023): 649–652. Accessed June 3, 2026. https://www.pnrjournal.com/index.php/home/article/view/7066.